Experts: Look to states and the courts for shifts in vaccine policy
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesCoronavirus/COVID-19Health Authority meeting and communication strategyPublic healthQuality Assurance and ControlUnited StatesUS Food and Drug Administration (FDA)